Home/Filings/4/0001209191-23-044892
4//SEC Filing

Hull Hans 4

Accession 0001209191-23-044892

CIK 0001746473other

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 8:50 PM ET

Size

20.6 KB

Accession

0001209191-23-044892

Insider Transaction Report

Form 4
Period: 2023-08-03
Hull Hans
Chief Business Officer
Transactions
  • Sale

    Common Stock

    2023-08-03$20.00/sh13,069$261,380206,114 total
  • Sale

    Common Stock

    2023-08-03$20.00/sh+1,800$36,000206,114 total
  • Exercise/Conversion

    Common Stock

    2023-08-03$2.08/sh+1,800$3,744207,914 total
  • Exercise/Conversion

    Common Stock

    2023-08-04$2.08/sh+8,791$18,285214,905 total
  • Sale

    Common Stock

    2023-08-04$20.01/sh20,050$401,201194,855 total
  • Exercise/Conversion

    Common Stock (Right to Buy)

    2023-08-031,80040,158 total
    Exercise: $2.08Exp: 2028-03-31Common Stock (1,800 underlying)
  • Exercise/Conversion

    Common Stock (Right to Buy)

    2023-08-048,79131,367 total
    Exercise: $2.08Exp: 2028-03-31Common Stock (8,791 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    3,821
  • Common Stock

    (indirect: See footnote)
    13,985
  • Common Stock

    (indirect: See footnote)
    13,985
Footnotes (7)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 3, 2023.
  • [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.01, inclusive. The Reporting Person undertakes to provide Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.08, inclusive. The Reporting Person undertakes to provide Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
  • [F4]The shares are held by The Sloger Hull Family Trust. The Reporting Person and his spouse serve as trustees for the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.
  • [F5]The shares are held by a trust for the Reporting Person's minor child ("Child A Trust"). The Reporting Person and his spouse serve as trustees for Child A Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F6]The shares are held by a trust for the Reporting Person's minor child ("Child B Trust"). The Reporting Person and his spouse serve as trustees for Child B Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F7]On January 24, 2019, the Reporting Person was granted stock options, the vesting of which was subject to the achievement of pre-established performance criteria which were achieved, and all of which were subject to the Reporting Person's continuous service to the Issuer.

Issuer

PLIANT THERAPEUTICS, INC.

CIK 0001746473

Entity typeother

Related Parties

1
  • filerCIK 0001614876

Filing Metadata

Form type
4
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 8:50 PM ET
Size
20.6 KB